New patent publication - Promunel modulates innate immune system

22/05/2025

Immune health 29% fewer upper respiratory discomfort events during the cough and cold season.

At Vitafoods Europe today, new scientific data on Promunel, the propolis-based ingredient for immune & respiratory health will be showcased.

Promunel is a brown propolis extract obtained from the patented Multi Dynamic Extraction process, guaranteeing a standardised full spectrum of polyphenols.


NEW CLINICAL STUDY

A new clinical study, double blind, randomized, placebo-controlled on 295 subjects, confirms the role of Promunel in supporting immune health by reducing the incidence and risk of respiratory discomforts.

  • 29% reduction in the incidence of upper respiratory discomfort
  • 34% shorter duration of discomfort episodes
  • 31% lower risk of experiencing seasonal upper respiratory challenges

DOWNLOAD THE BROCHURE

 

NEW PATENT APPLICATION PUBLISHED

A complete characterisation of the bioactive polyphenols of Promunel has been conducted: 96% of the propolis polyphenol fingerprint is identified.

An ex vivo study has demonstrated the immunomodulatory role of Promunel through macrophage polarisation.

Reference: Published patent application FR3154315


Promunel - new patent application published

 DOWNLOAD THE PREVIEW

 

Meet us at Vitafoods Barcelona 2025 - ABbiotek Health Fytexia Anzchem

This website is intended to provide information about Fytexia’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business to business and to provide information to food/dietary supplement professionals and is not designed for the general public.  Statements used on this website have not been evaluated by the Food and Drug Administration or any other competent authority. Products are not intended to diagnose, treat, cure or prevent any disease.